Mutation of HERC2 causes developmental delay with Angelman-like features

Background Deregulation of the activity of the ubiquitin ligase E6AP (UBE3A) is well recognised to contribute to the development of Angelman syndrome (AS). The ubiquitin ligase HERC2, encoded by the HERC2 gene is thought to be a key regulator of E6AP. Methods and results Using a combination of autozygosity mapping and linkage analysis, we studied an autosomal-recessive neurodevelopmental disorder with some phenotypic similarities to AS, found among the Old Order Amish. Our molecular investigation identified a mutation in HERC2 associated with the disease phenotype. We establish that the encoded mutant HERC2 protein has a reduced half-life compared with its wild-type counterpart, which is associated with a significant reduction in HERC2 levels in affected individuals. Conclusions Our data implicate a model in which disruption of HERC2 function relates to a reduction in E6AP activity resulting in neurodevelopmental delay, suggesting a previously unrecognised role of HERC2 in the pathogenesis of AS.

[1]  K Lange,et al.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.

[2]  Alfred Wittinghofer,et al.  The 1.7 Å crystal structure of the regulator of chromosome condensation (RCC1) reveals a seven-bladed propeller , 1998, Nature.

[3]  M. Lyon,et al.  A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. J. Driscoll,et al.  Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. , 1999, American journal of human genetics.

[5]  L. Stubbs,et al.  The ancestral gene for transcribed, low-copy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities. , 1999, Human molecular genetics.

[6]  E. Eichler,et al.  Structure of chromosomal duplicons and their role in mediating human genomic disorders. , 2000, Genome research.

[7]  R. Schultz,et al.  Structure of the highly conserved HERC2 gene and of multiple partially duplicated paralogs in human. , 2000, Genome research.

[8]  D. J. Driscoll,et al.  Distinct phenotypes distinguish the molecular classes of Angelman syndrome , 2001, Journal of medical genetics.

[9]  E. Eichler,et al.  Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. , 2003, American journal of human genetics.

[10]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[11]  J. L. Rosa,et al.  The HERC proteins: functional and evolutionary insights , 2005, Cellular and Molecular Life Sciences CMLS.

[12]  A. Beaudet,et al.  Angelman syndrome 2005: Updated consensus for diagnostic criteria , 2006, American journal of medical genetics. Part A.

[13]  Hans Eiberg,et al.  Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression , 2008, Human Genetics.

[14]  J. L. Rosa,et al.  The RCC1 superfamily: from genes, to function, to disease. , 2008, Biochimica et biophysica acta.

[15]  F. Hildebrandt,et al.  NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. , 2008, Journal of the American Society of Nephrology : JASN.

[16]  J. Fryns,et al.  Angelman syndrome (AS, MIM 105830) , 2009, European Journal of Human Genetics.

[17]  Aaron Ciechanover,et al.  Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome , 2010, Proceedings of the National Academy of Sciences.

[18]  T. Ohta,et al.  HERC 2 Is an E 3 Ligase That Targets BRCA 1 for Degradation , 2010 .

[19]  M. Cubillos-Rojas,et al.  Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris‐acetate polyacrylamide gels , 2010, Electrophoresis.

[20]  T. Ohta,et al.  HERC2 is an E3 ligase that targets BRCA1 for degradation. , 2010, Cancer research.

[21]  K. Buiting,et al.  Molecular and Clinical Aspects of Angelman Syndrome , 2011, Molecular Syndromology.

[22]  A. Ciechanover,et al.  Physical and Functional Interaction of the HECT Ubiquitin-protein Ligases E6AP and HERC2* , 2011, The Journal of Biological Chemistry.